Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL

K-Number: K211672 · 2021-10-20

Decision Date2021-10-20
Product CodeJWY
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL is a medical device manufactured by Liofilchem s.r.l.. It received FDA 510(k) clearance on 2021-10-20 under approval number K211672. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL?

MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL is a medical device that received FDA 510(k) clearance on 2021-10-20. It is manufactured by Liofilchem s.r.l.. The 510(k) number is K211672.

When was MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL approved by the FDA?

MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL received FDA 510(k) clearance on 2021-10-20, under approval number K211672.

What company makes MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL?

MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL is manufactured by Liofilchem s.r.l..

What is the FDA product code for MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL?

The FDA product code for MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL is JWY.

Other Devices by Liofilchem s.r.l.

View all 35 devices →

Related Devices (Code: JWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.